2nd Next Gen Inhalation Delivery Summit
Evvnt Promotion / evvnt
04.06.2024 - 06.06.2024 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 7:30 AM - 5:00 PM
Temi della conferenza
In an era marked by remarkable advancements, the inhalation therapy field is rapidly evolving. From Avalyn's $175 million investment in inhaled pulmonary fibrosis trials to Krystal Biotech's FDA clearance for inhaled gene therapy and MIT engineers' work on inhaled nanoparticles, the field is abuzz with new advances and breakthroughs in inhalation delivery.
In an era marked by remarkable advancements, the inhalation therapy field is rapidly evolving. From Avalyn's $175 million investment in inhaled pulmonary fibrosis trials to Krystal Biotech's FDA clearance for inhaled gene therapy and MIT engineers' work on inhaled nanoparticles, the field is abuzz with new advances and breakthroughs in inhalation delivery.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2262398-0?pid=4832
Speakers: Anna Cheng, Director - R and D Pulmonary Drug Delivery, Feldan Therapeutics , Colin Scott, CEO, Highland Airs Consultancy, Jaap Wieling, CEO, PureIMS, and more
URL:
Brochure: https://go.evvnt.com/2262398-0?pid=4832
Speakers: Anna Cheng, Director - R and D Pulmonary Drug Delivery, Feldan Therapeutics , Colin Scott, CEO, Highland Airs Consultancy, Jaap Wieling, CEO, PureIMS, and more
Informazioni ed Iscrizioni:
Ms. Nandita Iyer
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
